Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Sanofi
|
| gptkbp:acquisitionYear |
2011
|
| gptkbp:CEO |
David Meeker (prior to acquisition)
|
| gptkbp:focusArea |
genetic disorders
rare diseases |
| gptkbp:foundedIn |
1981
|
| gptkbp:founder |
gptkb:Sheridan_Snyder
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Genzyme Corporation
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Aldurazyme
gptkb:Cerezyme gptkb:Fabrazyme gptkb:Myozyme |
| gptkbp:numberOfEmployees |
over 10,000 (before acquisition)
|
| gptkbp:parentCompany |
gptkb:Sanofi
|
| gptkbp:stockSymbol |
gptkb:GENZ
|
| gptkbp:subsidiary |
gptkb:Sanofi
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
www.genzyme.com
|
| gptkbp:bfsParent |
gptkb:Genzyme_Center
|
| gptkbp:bfsLayer |
6
|